Zobrazeno 1 - 10
of 171
pro vyhledávání: '"Messino, M"'
Autor:
Fuchs, M.A., Yuan, C., Sato, K., Niedzwiecki, D., Ye, X., Saltz, L.B., Mayer, R.J., Mowat, R.B., Whittom, R., Hantel, A., Benson, A., Atienza, D., Messino, M., Kindler, H., Venook, A., Innocenti, F., Warren, R.S., Bertagnolli, M.M., Ogino, S., Giovannucci, E.L., Horvath, E., Meyerhardt, J.A., Ng, K. *
Publikováno v:
In Annals of Oncology June 2017 28(6):1359-1367
Autor:
Cheng E; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Ou FS; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN., Ma C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Spiegelman D; Department of Biostatistics, Yale School of Public Health, New Haven, CT.; Center on Methods for Implementation and Prevention Science, Yale School of Public Health, New Haven, CT., Zhang S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Zhou X; Department of Biostatistics, Yale School of Public Health, New Haven, CT.; Center on Methods for Implementation and Prevention Science, Yale School of Public Health, New Haven, CT., Bainter TM; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN., Saltz LB; Memorial Sloan Kettering Cancer Center, New York, NY., Niedzwiecki D; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC., Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Whittom R; Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada., Hantel A; Loyola University, Stritch School of Medicine, Naperville, IL., Benson A; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Atienza D; Virginia Oncology Associates, Norfolk, VA., Messino M; Messino Cancer Centers, Asheville, NC., Kindler H; University of Chicago, Chicago, IL., Giovannucci EL; Department of Epidemiology, and Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA., Van Blarigan EL; Department of Epidemiology and Biostatistics, and Urology, University of California, San Francisco, CA., Brown JC; Cancer Metabolism Program, Pennington Biomedical Research Center, Baton Rouge, LA., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Gross CP; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.; Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale Cancer Center, New Haven, CT., Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fuchs CS; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.; Division of Hematology and Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Yale Cancer Center, Smilow Cancer Hospital, New Haven, CT.; Hematology and Oncology Product Development, Genentech & Roche, South San Francisco, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Mar 01; Vol. 40 (7), pp. 740-751. Date of Electronic Publication: 2022 Jan 07.
Autor:
Van Blarigan EL; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco.; Department of Urology, University of California at San Francisco, San Francisco., Ou FS; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Bainter TM; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Fuchs CS; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Niedzwiecki D; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina., Zhang S; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Saltz LB; Memorial Sloan Kettering Cancer Center, New York, New York., Mayer RJ; Dana-Farber Cancer Institute, Boston, Massachusetts., Hantel A; Edward Hematology Oncology Group, Naperville, Illinois., Benson AB 3rd; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois., Atienza D; Virginia Oncology Associates, Norfolk., Messino M; Southeast Clinical Oncology Research Consortium, Mission Hospitals, Inc, Asheville, North Carolina., Kindler HL; University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Venook AP; Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco, San Francisco., Ogino S; Program in Molecular Pathology Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge., Sanoff HK; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill., Giovannucci EL; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Ng K; Dana-Farber Cancer Institute, Boston, Massachusetts., Meyerhardt JA; Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Feb 01; Vol. 5 (2), pp. e220145. Date of Electronic Publication: 2022 Feb 01.
Autor:
Lee S; Yale School of Medicine, New Haven, CT, USA., Zhang S; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA, USA., Ma C; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA, USA., Ou FS; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA., Wolfe EG; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA., Ogino S; Department of Oncologic Pathology, Dana-Farber/Partners CancerCare and Harvard Medical School, Boston, MA, USA.; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Niedzwiecki D; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Saltz LB; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mayer RJ; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA, USA., Mowat RB; Toledo Community Hospital Oncology Program, Toledo, OH, USA., Whittom R; Hôpital du Sacré-Coeur de Montréal, Montreal, Canada., Hantel A; Loyola University Stritch School of Medicine, Naperville, IL, USA., Benson A; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Atienza D; Virginia Oncology Associates, Norfolk, VA, USA., Messino M; Southeast Clinical Oncology Research Consortium, Mission Hospitals, Asheville, NC, USA., Kindler H; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Venook A; University of California at San Francisco Comprehensive Cancer Center, San Francisco, CA, USA., Gross CP; Yale School of Medicine, Department of Internal Medicine, New Haven, CT, USA., Irwin ML; Yale School of Public Health, New Haven, CT, USA., Meyerhardt JA; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA, USA., Fuchs CS; Yale School of Medicine, New Haven, CT, USA.; Yale Cancer Center, Smilow Cancer Hospital and Yale School of Medicine, New Haven, CT, USA.; Genentech, South San Francisco, CA, USA.
Publikováno v:
JNCI cancer spectrum [JNCI Cancer Spectr] 2021 Apr 12; Vol. 5 (3). Date of Electronic Publication: 2021 Apr 12 (Print Publication: 2021).
Autor:
Rajaie, Seyede Hamide1,2 (AUTHOR), Khayyatzadeh, Sayyed Saeid1,2 (AUTHOR), Faghih, Shiva3 (AUTHOR), Mansoori, Yaser4 (AUTHOR), Naghizadeh, Mohammad Mehdi4 (AUTHOR), Farjam, Mojtaba4 (AUTHOR), Homayounfar, Reza5 (AUTHOR) r_homayounfar@yahoo.com, Mozaffari-Khosravi, Hassan1,2 (AUTHOR) mozaffari.kh@gmail.com, Aihara, Ken-ichi (AUTHOR) aihara@tokushima-u.ac.jp
Publikováno v:
BioMed Research International. 7/16/2024, Vol. 2024, p1-12. 12p.
Autor:
Messino, M., Pergolotti, M., Jolly, T. A., Moore, S. G., Muss, H. B., Gordon, B.-B. E., Deal, A. M., Wood, W. A., Williams, G. R., Taylor, W. C., Dixon, S. A., Nyrop, K. A., Alston, S. M.
We investigated whether a brief geriatric assessment (GA) would identify important patient deficits that could affect treatment tolerance and care outcomes within a sample of older cancer patients rated as functionally normal (80%–100%) on the Karn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c45425502f72398922aab59fe56dd14c
Autor:
Cheng E; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut., Zhang S; Division of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts., Ou FS; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Mullen B; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Ng K; Division of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts., Saltz LB; Memorial Sloan Kettering Cancer Center, New York, New York., Niedzwiecki D; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina., Mayer RJ; Division of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts., Mowat RB; Toledo Community Hospital Oncology Program, Toledo, Ohio., Whittom R; Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada., Hantel A; Loyola University, Stritch School of Medicine, Naperville, Illinois., Benson A; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois., Atienza D; Virginia Oncology Associates, Norfolk, Virginia., Messino M; Southeast Cancer Oncology Research Consortium, Mission Hospitals, Asheville, North Carolina., Kindler H; University of Chicago, Chicago, Illinois., Giovannucci EL; Department of Epidemiology and Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Van Blarigan EL; Department of Epidemiology and Biostatistics and Department of Urology, University of California, San Francisco, California., Meyerhardt JA; Division of Medical Oncology, Dana-Farber/Partners Cancer Care, Boston, Massachusetts., Fuchs CS; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut. charles.fuchs@yale.edu.; Division of Hematology and Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.; Yale Cancer Center, New Haven, Connecticut.
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2020 Aug; Vol. 29 (8), pp. 1692-1695. Date of Electronic Publication: 2020 Jun 04.
Autor:
Okinaka, Tomohide1 (AUTHOR), Fujimura, Kenjiro2 (AUTHOR), Hamasaki, Yuka3 (AUTHOR), Hasegawa, Yuichi1 (AUTHOR), Matono, Takashi1 (AUTHOR) tmatonoh1@aih-net.com
Publikováno v:
BMC Infectious Diseases. 4/12/2024, Vol. 24 Issue 1, p1-6. 6p.
Autor:
Morales-Oyarvide V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Yuan C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Babic A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Zhang S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Niedzwiecki D; Alliance Statistics and Data Center, Duke University, Durham, NC., Brand-Miller JC; Institute of Obesity, Nutrition, and Exercise, University of Sydney, Sydney, Australia., Sampson-Kent L; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA., Ye X; Alliance Statistics and Data Center, Duke University, Durham, NC., Li Y; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA., Saltz LB; Memorial Sloan Kettering Cancer Center, New York, NY., Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Mowat RB; Toledo Community Hospital Oncology Program, Toledo, OH., Whittom R; Hôpital du Sacré-Coeur de Montréal, Montreal, Canada., Hantel A; Loyola University Stritch School of Medicine, Naperville, IL., Benson A; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Atienza D; Virginia Oncology Associates, Norfolk, VA., Messino M; Southeast Clinical Oncology Research Consortium, Mission Hospitals, Asheville, NC., Kindler H; University of Chicago Comprehensive Cancer Center, Chicago, IL., Venook A; University of California at San Francisco Comprehensive Cancer Center, San Francisco, CA., Ogino S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Department of Pathology, Harvard Medical School, Boston, MA., Wu K; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA., Willett WC; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA.; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA., Giovannucci EL; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA.; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA., Wolpin BM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fuchs CS; Yale Cancer Center, Smilow Cancer Hospital and Yale School of Medicine, New Haven, CT., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2019 Feb 01; Vol. 111 (2), pp. 170-179.
Autor:
Peppoloni, S, Felici, F, Ricci, S, Oggioni, M, Pozzi, G, Ardizzoni, A, Colombari, B, Orsi, C, Messino, M, LO PASSO, Carla, Pernice, Ida, Teti, Giuseppe, Ruggeri, A, E. BENINATI C.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3978::8012ec5db94f39d8dc8ed75984431ce2
http://hdl.handle.net/11570/1866208
http://hdl.handle.net/11570/1866208